These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15746669)

  • 1. Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain.
    Williams RE; Hartmann KE; Sandler RS; Miller WC; Savitz LA; Steege JF
    Am J Obstet Gynecol; 2005 Mar; 192(3):761-7. PubMed ID: 15746669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of irritable bowel syndrome among women with chronic pelvic pain.
    Williams RE; Hartmann KE; Sandler RS; Miller WC; Steege JF
    Obstet Gynecol; 2004 Sep; 104(3):452-8. PubMed ID: 15339753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
    Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
    Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
    Cremonini F; Talley NJ
    Minerva Med; 2004 Oct; 95(5):427-41. PubMed ID: 15467518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
    Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
    Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
    Mangel AW; Bornstein JD; Hamm LR; Buda J; Wang J; Irish W; Urso D
    Aliment Pharmacol Ther; 2008 Jul; 28(2):239-49. PubMed ID: 18466359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
    Chang FY; Lu CL; Chen CY; Luo JC
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of irritable bowel syndrome among patients with mild-moderate and severe chronic pelvic pain.
    Tachawiwat K; Cheewadhanaraks S
    J Med Assoc Thai; 2012 Oct; 95(10):1257-60. PubMed ID: 23193737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower gastrointestinal disorders in patients with irritable bowel syndrome.
    Jurcić D; Bilić A; Schwarz D; Luetic K; Marusić M; Vcev A; Gabrić M; Spoljarić L
    Coll Antropol; 2008 Sep; 32(3):755-9. PubMed ID: 18982748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Vicari E; Salemi M; Sidoti G; Malaguarnera M; Castiglione R
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29099760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic pelvic pain in the community--symptoms, investigations, and diagnoses.
    Zondervan KT; Yudkin PL; Vessey MP; Jenkinson CP; Dawes MG; Barlow DH; Kennedy SH
    Am J Obstet Gynecol; 2001 May; 184(6):1149-55. PubMed ID: 11349181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tegaserod in treatment of women with irritable bowel syndrome].
    Munck LK; Ainsworth MA
    Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional bowel and anorectal disorders in patients with pelvic organ prolapse and incontinence.
    Jelovsek JE; Barber MD; Paraiso MF; Walters MD
    Am J Obstet Gynecol; 2005 Dec; 193(6):2105-11. PubMed ID: 16325624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
    Chey WD; Paré P; Viegas A; Ligozio G; Shetzline MA
    Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
    Leventer SM; Raudibaugh K; Frissora CL; Kassem N; Keogh JC; Phillips J; Mangel AW
    Aliment Pharmacol Ther; 2008 Jan; 27(2):197-206. PubMed ID: 17973974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal pain impacts quality of life in women with irritable bowel syndrome.
    Cain KC; Headstrom P; Jarrett ME; Motzer SA; Park H; Burr RL; Surawicz CM; Heitkemper MM
    Am J Gastroenterol; 2006 Jan; 101(1):124-32. PubMed ID: 16405544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.
    Malagelada JR
    Int J Clin Pract; 2006 Jan; 60(1):57-63. PubMed ID: 16409429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.